晚期上皮性卵巢癌全身治疗相关影像学表现概述
本文面向放射科医生,概述晚期上皮性卵巢癌(EOC)所用全身治疗药物及其相关毒性反应的影像学特征;EOC 诊断时多为晚期,虽以初次肿瘤细胞减灭术和化疗为主要治疗,但复发率高,近十年多种分子靶向药物显示疗效,熟悉这些药物及其毒性的影像表现对诊断图像解读至关重要。
要点
- 晚期上皮性卵巢癌常用全身治疗包括化疗及多种分子靶向药物。
- 识别全身治疗相关毒性反应的影像学特征对诊断图像解读至关重要。
- 影像科医生需了解靶向药物毒性表现以准确判读复查图像。
核心结论
- 掌握晚期上皮性卵巢癌所用全身治疗及其相关影像学特征对诊断图像解读至关重要。
研究设计与样本
- 本文为面向放射科医生的概述性文章,总结晚期上皮性卵巢癌的全身治疗药物及其相关毒性影像表现。
临床应用与阅片要点
- 放射科医生在判读晚期上皮性卵巢癌患者图像时,应了解其所用全身治疗药物及相关毒性影像特征以辅助诊断解读。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To provide an overview for radiologists of the systemic agents used in the treatment of advanced epithelial ovarian cancer (EOC) and their associated toxicities.
RESULTS: EOC is a common gynecological malignancy, with the majority of patients presenting with advanced stage disease at the time of diagnosis. Although primary cytoreductive surgery and chemotherapy are the principal treatments for EOC, recurrence rates of disease remain high. As several molecular targeted therapies have been developed in the last decade, various novel agents have shown efficacy in the treatment of advanced EOC. Advanced EOC will be discussed by outlining the relevant radiological features of toxicities.
CONCLUSION: Knowledge of the systemic therapies utilized in the treatment of advanced EOC and their associated radiological features is critical in diagnostic image interpretation.
引用
- Guler E, Smith DA, Somarouthu B, et al. Overview of imaging findings associated with systemic therapies in advanced epithelial ovarian cancer. Abdom Radiol (NY). 2020. PMID: 31396642. doi:10.1007/s00261-019-02175-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。